https://www.ndtvprofit.com/research-reports/thyrocare-stimulating-model-to-restore-profitability-icici-securities?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
Leveraging its dominance in the B2B diagnostic business in India, Thyrocare’s new management has charted a roadmap to boost strong 15–17% growth in its base business of pathology